These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38695888)

  • 21. Can We Predict Individual Concentrations of Tacrolimus After Liver Transplantation? Application and Tweaking of a Published Population Pharmacokinetic Model in Clinical Practice.
    Decrocq-Rudler MA; Chan Kwong AHP; Meunier L; Fraisse J; Ursic-Bedoya J; Khier S
    Ther Drug Monit; 2021 Aug; 43(4):490-498. PubMed ID: 33560099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients.
    Benkali K; Prémaud A; Picard N; Rérolle JP; Toupance O; Hoizey G; Turcant A; Villemain F; Le Meur Y; Marquet P; Rousseau A
    Clin Pharmacokinet; 2009; 48(12):805-16. PubMed ID: 19902988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
    Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
    J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited sampling strategies for monitoring tacrolimus in pediatric liver transplant recipients.
    Delaloye JR; Kassir N; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Labbé L; Théorêt Y; Litalien C
    Ther Drug Monit; 2011 Aug; 33(4):380-6. PubMed ID: 21743386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population Pharmacokinetics and Bayesian Estimators for Refined Dose Adjustment of a New Tacrolimus Formulation in Kidney and Liver Transplant Patients.
    Woillard JB; Debord J; Monchaud C; Saint-Marcoux F; Marquet P
    Clin Pharmacokinet; 2017 Dec; 56(12):1491-1498. PubMed ID: 28389935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a population PK model of tacrolimus for adaptive dosage control in stable kidney transplant patients.
    Andreu F; Colom H; Grinyó JM; Torras J; Cruzado JM; Lloberas N
    Ther Drug Monit; 2015 Apr; 37(2):246-55. PubMed ID: 25254416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies.
    Saint-Marcoux F; Knoop C; Debord J; Thiry P; Rousseau A; Estenne M; Marquet P
    Clin Pharmacokinet; 2005; 44(12):1317-28. PubMed ID: 16372829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients.
    Kassir N; Labbé L; Delaloye JR; Mouksassi MS; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Théorêt Y; Litalien C
    Br J Clin Pharmacol; 2014 Jun; 77(6):1051-63. PubMed ID: 24977292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of tacrolimus dosage in the early period after heart transplantation: a population pharmacokinetic approach.
    Han Y; Zhou H; Cai J; Huang J; Zhang J; Shi SJ; Liu YN; Zhang Y
    Pharmacogenomics; 2019 Jan; 20(1):21-35. PubMed ID: 30730287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction tacrolimus blood levels based on the Bayesian method in adult kidney transplant patients.
    Antignac M; Fernandez C; Barrou B; Roca M; Favrat JL; Urien S; Farinotti R
    Eur J Drug Metab Pharmacokinet; 2011 Mar; 36(1):25-33. PubMed ID: 21347736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients.
    Zhao W; Fakhoury M; Baudouin V; Maisin A; Deschênes G; Jacqz-Aigrain E
    Ther Drug Monit; 2011 Dec; 33(6):681-7. PubMed ID: 22011724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. External evaluation of published population pharmacokinetic models of polymyxin B.
    Li YQ; Chen KF; Ding JJ; Tan HY; Yang N; Lin YQ; Wu CF; Xie YL; Yang GP; Liu JJ; Pei Q
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1909-1917. PubMed ID: 34342716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients.
    Zahir H; McLachlan AJ; Nelson A; McCaughan G; Gleeson M; Akhlaghi F
    Ther Drug Monit; 2005 Aug; 27(4):422-30. PubMed ID: 16044097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients.
    Sam WJ; Aw M; Quak SH; Lim SM; Charles BG; Chan SY; Ho PC
    Br J Clin Pharmacol; 2000 Dec; 50(6):531-41. PubMed ID: 11136292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling.
    Størset E; Holford N; Hennig S; Bergmann TK; Bergan S; Bremer S; Åsberg A; Midtvedt K; Staatz CE
    Br J Clin Pharmacol; 2014 Sep; 78(3):509-23. PubMed ID: 25279405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetics of immediate- and prolonged-release tacrolimus formulations in liver, kidney and heart transplant recipients.
    Lu Z; Bonate P; Keirns J
    Br J Clin Pharmacol; 2019 Aug; 85(8):1692-1703. PubMed ID: 30950096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.
    Fukudo M; Yano I; Masuda S; Goto M; Uesugi M; Katsura T; Ogura Y; Oike F; Takada Y; Egawa H; Uemoto S; Inui K
    Clin Pharmacol Ther; 2006 Oct; 80(4):331-45. PubMed ID: 17015051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients.
    Chen B; Shi HQ; Liu XX; Zhang WX; Lu JQ; Xu BM; Chen H
    J Clin Pharm Ther; 2017 Dec; 42(6):679-688. PubMed ID: 28833329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
    Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
    PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review.
    Kirubakaran R; Stocker SL; Hennig S; Day RO; Carland JE
    Clin Pharmacokinet; 2020 Nov; 59(11):1357-1392. PubMed ID: 32783100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.